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Protein transduction domaina family of enzymes that are traditionally known to contribute to the phase II
class of detoxiﬁcation reactions. However, a novel property of the Schistosoma japonicum glutathione
transferase (Sj.GST26) involves its translocation from the external medium into a variety of different cell
types. Here we explore the efﬁciency and mechanism of cell entry for this class of protein. Using ﬂow
cytometry and confocal microscopy, we have examined the internalisation of Sj.GST26 into live cells under a
variety of conditions designed to shed light on the mode of cellular uptake. Our results show that Sj.GST26
can effectively enter cells through an energy-dependent event involving endocytosis. More speciﬁcally, Sj.
GST26 was found to colocalise with transferrin within the cell indicating that the endocytosis process
involves clathrin-coated pits. A comprehensive study into the cellular internalisation of proteins from other
classes within the GST structural superfamily has also been conducted. These experiments suggest that the
‘GST-fold’ structural motif inﬂuences cellular uptake, which presents a novel glimpse into an unknown aspect
of GST function.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
The cellular membrane performs the dual role of allowing
selective passage of speciﬁc biological molecules into the cell, whilst
simultaneously acting as a formidable barrier that blocks the free
exchange of molecules between the cytoplasm and extracellular
environment. The fundamental structure of membranes is the
phospholipid bilayer, into which various proteins, glycolipids and
cholesterol are inserted. A vast array of molecules have the ability to
cross the cellular membrane either by diffusion processes or by
protein-mediated mechanisms that involve transport proteins and
ion channels. Such molecules are responsible not only for cell
maintenance and function, but in some cases also have the ability to
trigger cell death [1]. Intriguingly, it has been reported in a
qualitative study that a glutathione transferase (GST) from Schisto-
soma japonicum (Sj.GST26) can be internalised from the medium into
a variety of mammalian cell types [2,3].GST, glutathione transferase;
, chloride intracellular channel
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ll rights reserved.GSTs are a family of enzymes that are generally considered to
contribute to the phase II class of detoxiﬁcation reactions. In this role
they conjugate the tripeptide glutathione (GSH) to a wide range of
electrophilic and generally hydrophobic compounds that may be of
endogenous or exogenous origin. Whilst there are reports of GSTs
interacting with cell membranes [4,5], so far there has been no
physiological role identiﬁed for a complete extra- to intracellular
translocation of exogenous cytosolic GSTs. Therefore it is unclear
whether the observed translocation of Sj.GST26 is an isolated, non-
speciﬁc event, or indeed whether this family of enzymes could
represent a novel class of proteins capable of efﬁciently entering cells.
Despite the relatively low sequence homology between classes,
all cytosolic GSTs share the same general structure — an N-terminal
thioredoxin fold motif and a strongly helical C-terminal domain as
shown in Fig. 1. Together this structure has been termed the ‘GST-
fold’. In the current study we have quantitatively investigated the
entry of Sj.GST26 into cells through a series of experiments that
consider the efﬁciency, mechanism and speciﬁcity associated with
cellular uptake. In light of our results, we expanded the scope of this
research to consider different classes of mammalian cytosolic GSTs,
as well as other proteins that possess a GST structural fold but do not
exhibit any known GST enzyme activity. Furthermore, the effect of
mutating key, active-site residues related to GST enzyme function
was examined with respect to cell entry. Our results show that Sj.
GST26 enters cells with an efﬁciency comparable to the receptor-
mediated transferrin ligand, and that the mechanism of cell entry
involves endocytosis. We ﬁnd that the ability of Sj.GST26 to enter
cells extends not only to other GST enzymes, but also to molecules
Fig. 1. Structural GST-fold. Ribbon diagram demonstrating the GST-fold structure of Sj.
GST26 complexed to glutathione sulfonic acid. Note the N-terminal thioredoxin fold and
C-terminal α-helices. The ﬁgure was generated by the use of the DS modelling 1.1
program (Accelrys) from the accession bank ﬁle RCSB_1M99.
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tion is independent of GST enzyme function.
2. Materials and methods
2.1. Materials
Bovine serum albumin and all cellular inhibitors were purchased
from Sigma, with the exception of sodium azide (Ajax Chemicals).
Neutral dextran-TexasRed (70 kDa), ER-Tracker™Red, BODIPY TR C5-
ceramide, human transferrin solution, Oregon Green 488 carboxylic
acid succinimidyl ester ‘5-isomer’ and Alexa Fluor 633 carboxylic acid
succinimidyl ester were from Molecular Probes. Human transferrin-
TRITC was from Jomar Diagnostics. 7-amino-actinomycin D (7-AAD)
was from BD PharMingen.
2.2. Expression and labelling of recombinant proteins
All proteins used in this studywith the exception of transferrin and
BSA, were expressed in E. coli and puriﬁed by afﬁnity chromatography.
GSTA1-1, GSTM2-2, GSTP1-1 and the S. japonicum GST (Sj.GST26)
were puriﬁed by glutathione agarose afﬁnity chromatography as
previously described [6–9]. Other GSTs (GSTO1-1, GSTZ1-1), GST-fold
proteins (CLIC2, GDAP1), and glutathione synthetase (GSH-S) which
do not bind to glutathione agarose were expressed with poly-His tags
and puriﬁed by nickel sepharose afﬁnity chromatography as described
previously [10–14]. Plasmids encoding the GST-fold proteins Ure2
from S. cerevisiae, and Glutaredoxin-2 (Grx2) from E. coli, were
constructed from ampliﬁed genomic DNA cloned into the pDEST17
vector (Invitrogen) using the Gateway cloning technology (Invitro-
gen). Poly-His tagged proteins were expressed overnight at 30 °C
using 1 mM IPTG and puriﬁed by nickel sepharose afﬁnity chromato-
graphy as described previously [15].
GST mutations were performed using the QuickChange site-
directedmutagenesis kit (Stratagene) and veriﬁed byDNA sequencing.
Puriﬁed proteins were dialysed into PBS prior to ﬂuorescent
labelling of primary aliphatic amines with Oregon Green succinimidyl
ester according to the manufacturer's instruction. Labelled proteins
were passed through size-exclusion sephadex columns then dialysed
for 48 h against PBS at 4 °C to ensure efﬁcient removal of free dye.
Protein concentration and ﬂuorophore to protein ratios were
calculated from protein absorbance at 280 nm and 496 nm according
to the manufacturer's labelling protocol. Commercial bovine serumalbumin and human transferrinwere reconstituted in PBS and labelled
with Oregon Green in the same manner. All Oregon Green-labelled
proteins were aliquoted and stored at −20 °C.
The cycle3 green ﬂuorescent protein (cyc3GFP) and mOrange
constructs were ampliﬁed from pDEST47 (Invitrogen) and pRSETB-
mOrange [16] respectively, and inserted into the Sj.GST26 expression
plasmid pDEST15 (Invitrogen) using the Gateway cloning method
(Invitrogen). Sj.GST26-cyc3GFP and Sj.GST26-mOrange fusion pro-
teins were expressed from pDEST15-GFP and pDEST15-mOrange
transformed BL21(DE3) cells overnight at 30 °C using 1 mM IPTG,
and puriﬁed by glutathione agarose afﬁnity chromatography as
described previously [9]. The eluted proteins were dialysed over-
night at 4 °C against PBS and concentrated using ultraﬁltration. The
puriﬁed Sj.GST26-mOrange protein was thiol-labelled with Oregon
Green 488 maleimide in the presence of TCEP, according to the
manufacturer's instruction. Thiol rather than amine-labelling was
performed to preferentially label only the GST portion of the fusion
protein (the mOrange protein contains no cysteines). Unreacted
ﬂuorophore was removed by dialysis overnight against PBS at 4 °C. A
standard curve of green/orange ﬂuorescence was constructed
using protein diluted in PBS adjusted to pH 4.5, 5.0, 5.5, 6.0, 6.5
and 7.0 using dual channel ﬂuorescence measured by ﬂuorescence
spectroscopy.
2.3. Cell culture
Cell lines were obtained from ATCC and routinely maintained in
RPMI 1640 medium, supplemented with 10% fetal bovine serum (FBS)
(v/v), 2 mM glutamine and 2 g/L NaHCO3 at 5% CO2 and 37 °C. Cultures
were passaged using PBS containing 0.05% trypsin and 0.02% EDTA (v/
v). All cell culture reagents were purchased from Gibco.
2.4. Flow cytometry
To quantitatively investigate the cellular uptake of all GST-fold
proteins, as well as the effect of various inhibitors upon this process, L-
929 cells were seeded at a density of 8×104 per well in 12-well plates
(Nunclon) in 10% FBS/RPMI 1640 medium. The next day cells were
rinsed with serum-free RPMI 1640 medium before addition of
inhibitors or ﬂuorescently-labelled proteins in serum-free medium.
Following protein incubation, cells were washed several times with
PBS and detached by trypsinization for 10 min at 37 °C. Cells were
centrifuged at 4 °C, washed in cold PBS containing 2% FBS (v/v) then
resuspended in 2% FBS/PBS containing 0.5 μg/mL 7-amino-actinomy-
cin D (7-AAD). Cells were incubated at room temperature in the dark
for 10 min prior to ﬂuorescence-activated cell sorting of 104 counts on
a FACScan ﬂow cytometer (Becton Dickinson). Cells with 7-AAD
ﬂuorescencewere considered nonviable and excluded from histogram
acquisition. The geometric mean ﬂuorescence of the viable population
was divided by the ﬂuorophore to protein ratio (calculated according
to labelling protocol— see method above) and this standardised value
considered representative of the amount of intracellular protein.
2.5. Quantiﬁcation of GST uptake
To compare the rate of uptake of various GST-fold proteins, and BSA
and GSH-S controls, the Oregon Green-labelled proteins were added
to cells in serum-free media at 200 nM concentration in a time course
over 3 h, and cells incubated at 37 °C/5% CO2. Untreated cells were
used for the initial zero time point. Samples were harvested and
prepared for ﬂow cytometry simultaneously as described above. The
geometric mean ﬂuorescence of viable cells in each incubation time
point was standardised to the ﬂuorophore to protein ratio for that
particular protein, as mentioned previously. In this manner the
intracellular ﬂuorescence of different proteins could be quantitatively
compared over time.
Fig. 2. Sj.GST26 uptake and localisation is independent of ﬂuorophore and cargo. L-929
cells were incubated for 1 h with 200 nM Sj.GST26-OG (A) or 2 μM Sj.GST26-cyc3GFP
(B), washed and then observed by confocal microscopy. In both cases ﬂuorescence is in a
punctate pattern in the cytoplasm. Different concentrations of the two proteins were
applied because the cycle3 GFP is a less effective ﬂuorophore than Oregon Green.
Fig. 3. Kinetics of extracellular Sj.GST26 internalisation. (A) L-929 cells were incubated
with 200 nM Oregon Green-labelled Sj.GST26 (■), Tfn (▴), BSA (X) or GSH-S (◊) for
the indicated time periods and intracellular ﬂuorescence measured by ﬂow cytometry.
The mean cell ﬂuorescence of each sample was normalised for the degree of
ﬂuorescent labelling of that protein. (B) Mean intracellular ﬂuorescence of L-929 cells
treated with Sj.GST26-OG (■) over a 24 h time period and measured by ﬂow
cytometry. Lack of 7-AAD (▴) permeability demonstrates cell viability. (C) Sample
ﬂuorescence of L-929 cells treated for 2 h with increasing concentrations of Sj.GST26-
OG, as assessed by ﬂuorescence spectroscopy. Data in all graphs is the average of three
independent experiments±SEM. (B) and (C) include a non-linear ﬁt using the one-site
binding hyperbola. Fluorescence values have been expressed as relative ﬂuorescence
units (RFU).
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The effect of increasing concentrations of Sj.GST26-OG on L-929
cells was investigated using a FLUOstar OPTIMA ﬂuorescent micro-
plate reader (BMG). L-929 cells were seeded into 96-well plates
(Nunclon) at a density of 1×104 cells per well in 10% FBS/RPMI 1640
medium and incubated overnight. The next day cells were incubated
for 2 h with 0.1–20 μM Sj.GST26-OG in serum-free RPMI. Cells were
then washed several times with PBS, and sample ﬂuorescence
measured in 10% FBS/PBS using a 485P excitation wavelength ﬁlter
and a 520P emission wavelength ﬁlter. The kinetics of cell samples
treated with trypsin to remove extracellular Sj.GST26-OG were also
examined and followed the same trend, although at a lower relative
ﬂuorescence level. The viability of treated cells was assayed by means
of plasma membrane integrity with Neutral Red and cellular ATP
levels.
2.7. Uptake in different cell types
Subconﬂuent cultures of the following cell lines were treated
with 200 nM Sj.GST26-OG for 2 h in serum-free medium, then
harvested and prepared for ﬂow cytometry as described above. NIH/
3T3 mouse embryo ﬁbroblast; HepG2 human hepatocyte carcinoma;
Hek-293 human kidney; EL4 mouse T lymphocyte lymphoma; Jurkat
human T lymphocyte leukemia; HeLa human cervical carcinoma; CV-
1 African Green monkey kidney; NIT-1 mouse pancreatic beta cell
insulinoma; PK(15) pig kidney; CHO-K1 Chinese hamster ovary; BT-
20 human breast carcinoma; T-47D human breast duct carcinoma;
JAWSII mouse myeloid immature dendritic cells; K-562 human
multipotent malignant hematopoietic cells; LF2 female mouse
embryonic stem cells.
Primary splenocytes were harvested from spleens of Balb/c and
C57BL/6 mice by red blood cell lysis and disassociation into single
cell suspension. Splenocytes were then incubated with 200 nM Sj.
GST26-OG for 2 h and prepared for ﬂow cytometry as described
above.2.8. Confocal laser scanning microscopy
Cells were seeded onto glass coverslips (Lomb Scientiﬁc) or Lab-
Tek II coverglass chambers (Nunc, In Vitro Technologies) in 10% FBS/
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were used in microscopy experiments to avoid the possibility of
artiﬁcial localisation, unless stated otherwise. All incubations were
performed in serum-free RPMI 1640 medium.
Sj.GST26-OG and Sj.GST26-cyc3GFP were incubated with cells for
1 h at 200 nM and 2 μM respectively. Sj.GST26-mOrange-OG was
incubated with cells at 100 nM for 2 h before addition of 400 nM
baﬁlomycin A1 for 30 min or continued incubation of control.
To investigate endocytosis pathways, cells were serum-starved for
30 min then co-incubated with 100 nM Sj.GST26-OG plus either
0.5 mg/mL neutral dextran-TexasRed (70 kDa) or 250 nM transferrin-
TRITC for 60 min.
To visualise the Golgi apparatus, cells were incubated with 5 μM
BODIPY TR C5-ceramide at 4 °C for 30min, rinsed, then incubated with
200 nM Sj.GST26-OG at 37 °C for 1 h in fresh medium. Sj.GST26
transport in golgi-disrupted cells was investigated by pretreatment
with 20 μM Brefeldin A followed by 200 nM Sj.GST26-OG incubation
for 1 h. To visualise the ER, cells were ﬁrst incubated with 200 nM Sj.
GST26-OG for 2 h at 37 °C followed by addition of 500 nM ER-
Tracker™Red for a further 15 min, then rinsed and incubated in fresh
medium for 10 min. Nuclei were visualised following a 1 h treatment
with 100 nM Sj.GST26-OG by ﬁxation in 1% paraformaldehydeFig. 4. Transduction of Sj.GST26 and BSA into various cell lines and primary cells. Cells were tr
cytometry as per standard procedure. The mean intracellular ﬂuorescence of each sample w
the average of duplicate measurements in two to four independent experiments+S.D., and(15 min, room temperature), and staining with 0.5 μg/ml 7-AAD for
20 min. No change to the morphology of Sj.GST26 ﬂuorescence was
observed after ﬁxation.
Following treatment cells were washed several times in PBS then
viewed immediately in pre-warmed RPMI (in the case of coverslips
within a 37 °C solution chamber). Confocal images were obtainedwith
60× 1.4 N.A. or 100× 1.4 N.A. oil immersion lenses of a Nikon Eclipse
TE300 microscope equipped with a Biorad Radiance 2000 Laser
Scanning system. Excitation was with argon and green helium neon
lasers (sequentially) using 515/30 bp and E570LP emission ﬁlters. Data
was recorded and analysed using LaserSharp2000 software.
3. Results
3.1. Kinetics of Sj.GST26 internalisation
Sj.GST26 has previously been shown to enter into cultured cells
through qualitativemicroscopymethods [2]. In order to quantitatively
assess the level and efﬁciency of cellular uptake, ﬂow cytometry was
employed tomeasure the intracellular accumulation of Oregon Green-
labelled proteins over time. Firstly though, to eliminate any involve-
ment from the Oregon Green ﬂuorophore in Sj.GST26 internalisation,eated for 2 hwith 200 nMOregon Green-labelled Sj.GST26 or BSA then prepared for ﬂow
as normalised for the degree of ﬂuorescent labelling of that protein. Data for Sj.GST26 is
for BSA is the average of duplicate measurements in a single experiment.
Fig. 5. Sj.GST26 internalisation is energy-dependent. L-929 cells were treated for up to
1 h with Sj.GST26-OG at low temperature (●), and in the presence (X) or absence (■) of
metabolic inhibitors at 37 °C. Themean intracellular ﬂuorescencewasmeasured by ﬂow
cytometry. To deplete cellular ATP levels, cells were treated with 0.1% sodium azide and
50 mM 2-deoxy-D-glucose for 1 h prior to the ﬁrst addition of Sj.GST26-OG. Inhibitors
were maintained in the medium for the duration of Sj.GST26 treatments. After
treatment with metabolic inhibitors, cellular ATP levels were measured and found to be
∼25% of untreated control levels using Sigma's Bioluminescent Somatic Cell Assay kit
with luminescence recorded in a 96-well plate on a Reporter Microplate 9600-001
Luminometer (Turner Biosystems). Error bars represent the S.D. of three independent
experiments.
Fig. 6. Sj.GST26 localises to acidic vesicles. Sj.GST26 localises to acidic vesicles. L-929
cells were treated with 100 nM Sj.GST26-mOrange-OG for 21/2 h (A) or 2 h plus 30 min
with 400 nM baﬁlomycin A1 to prevent endosome acidiﬁcation (B). Both samples were
washed and observed by confocal microscopy using the same laser settings for both
samples.
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with both Oregon Green-labelled Sj.GST26 and a Sj.GST26-cyc3GFP
ﬂuorescent fusion protein. Both the Oregon Green and GFP ﬂuores-
cence appeared in a punctate pattern throughout the cytoplasm of
cells (Fig. 2), conﬁrming that Sj.GST26 is capable of membrane
transduction independently of the ﬂuorophore employed.
Flow cytometry cannot distinguish between surface-bound and
internalised ﬂuorescence so each cell sample was treated with trypsin
to remove surface-bound proteins. Viable cells were then selected for
analysis of intracellular Oregon Green levels through their exclusion of
the membrane-impermeable 7-amino-actinomycin (7-AAD). Finally,
to compare the intracellular ﬂuorescence of different GST proteins,
mean cell ﬂuorescence values were corrected for differing levels of
protein ﬂuorescent-labelling. In this manner, intracellular accumula-
tion of different proteins over time can be graphically represented for
comparison of transduction efﬁciency.
A comparison of the rate of Sj.GST26 transduction into L-929 cells
over 2 h, to that of human transferrin, bovine serum albumin (BSA)
and human glutathione synthetase (GSH-S), is shown in Fig. 3A.
Transferrin is known to be transported into cells via clathrin-
mediated endocyosis and is commonly employed to probe the
mechanism and efﬁciency of cell entry of other molecules. BSA and
GSH-S were chosen as control proteins because of the comparable
size of BSA to the Sj.GST26 dimer, and because like GSTs, GSH-S
represents a glutathione associated enzyme. The rapidity of Sj.GST26
and transferrin internalisation above both control proteins suggests
that a speciﬁc and efﬁcient cellular mechanism is responsible for GST
transduction. The same kinetic transduction proﬁle was also
produced in HeLa, 4T1 and Hek-293 cell lines (data not shown).
The mouse ﬁbroblast L-929 cell line was chosen for further
mechanistic proﬁling of Sj.GST26 internalisation due to their normal,
non-cancerous morphology. In addition, the uniform monolayer
adherence and bipolar morphology of L-929 cells lends itself to clear
visualisation by microscopy.
Further analysis of cells incubated with Sj.GST26 (Fig. 3B) revealed
that transduction into viable cells continues for several hours before
reaching equilibrium. To determine if the uptake of Sj.GST26 is related
to concentration, L-929 cells were exposed to increasing concentra-
tions of Sj.GST26 and examined by ﬂuorescence spectroscopy after 2 h.
As can be seen in Fig. 3C, the accumulation of Sj.GST26 in cells reacheda plateau at concentrations above 10 μM. Even at high concentrations,
Sj.GST26 does not affect cell viability (data not shown— see Methods).
3.2. Internalisation of Sj.GST26 into different cell types
The ability of Sj.GST26 to translocate into a variety of cell lines and
primary tissue was assessed by ﬂow cytometry along with BSA. As
shown in Fig. 4, the capacity of different cell lines to speciﬁcally
internalise Sj.GST26 is variable and with no obvious relationship to
tissue type or disease status. For instance Sj.GST26 was able to
translocate into multipotent myeloid cells (K-562), mouse embryonic
stem cells (LF2) and primary splenocytes, but not T lymphocytes (EL4
and Jurkat), as judged by comparison of normalised Sj.GST26 and BSA
intracellular ﬂuorescence. Also, transduction into two breast carci-
noma lines (BT-20 and T-47D) differed widely. Although no trend for
Sj.GST26 internalisation is apparent from Fig. 4, this study clearly
shows that the accumulation of Sj.GST26 by cells is not an uncommon
occurrence.
3.3. Mechanism of Sj.GST26 transduction
Given that the punctate pattern of Sj.GST26 ﬂuorescence in cells is
reminiscent of endosomes in the cytoplasm, we assessed the
involvement of endocytosis in Sj.GST26 accumulation. The ability
of cells to internalise Sj.GST26 at 4 °C and the role of ATP in
transductionwere examined using ﬂow cytometry. As demonstrated
in Fig. 5, low temperature and cellular ATP depletion precluded
cellular uptake of Sj.GST26, indicating that Sj.GST26 internalisation
is an energy-dependent process. To probe the nature of the intra-
cellular environment of Sj.GST26, a Sj.GST26 fusion protein contain-
ing the pH-sensitive ﬂuorescent mOrange protein (pKa 6.5) was
created. Subsequent Oregon Green-labelling (pKa 4.7) of this
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ﬂuorophores were differentially sensitive to pH changes. After 2 h
incubation with the Sj.GST26-mOrange-OG molecule, strong green
ﬂuorescence could be visualised but only a faint orange signal. When
baﬁlomycin A1, a selective inhibitor of vacuolar H+-ATPases [17], was
subsequently added to cells however, a considerable increase in the level
of orangeﬂuorescencewas seen (Fig. 6). This novel experiment conﬁrms
that Sj.GST26 accumulates in acidic vesicles within cells. Control cells
incubated with the mOrange protein alone displayed no ﬂuorescence,
verifying that the Sj.GST26 portion of the fusion protein is responsible
for its cellular transport (data not shown).
3.4. Intracellular fate of Sj.GST26
The mechanism of endocytosis employed by a molecule plays a
critical role in determining its fate, both in terms of its destination and
stability. The nature of the Sj.GST26 endocytic route was probed using
traditional endocytosis ‘markers’ in confocal microscopy experiments.
These markers included transferrin for clathrin-mediated endocytosis
(CME) [18] and neutral dextran for macropinocytosis [19–21]. As
illustrated in Fig. 7, Sj.GST26 clearly colocalised with vesicles contain-
ing both ﬂuorescent markers. Since dextran is a ﬂuid-phase marker it
potentially has access not only to macropinosomes, but any endocytic
vesicle formed within cells provided they are large enough to
encapsulate the molecule [22]. It is therefore possible that this marker
does not exclusively represent macropinosomes. It must also be noted
that colocalisation with transferrin does not necessarily indicate CME.
Experiments using chlorpromazine and K+ depletion (which are both
known to affect CME) show that uptake is substantially reduced (see
Supplementary material).
To begin to understand the physiological functionality behind GST
transduction,we sought to further clarify the subcellular localisation ofFig. 7. Colocalisation between Sj.GST26 and different endocytic pathwaymarkers. L-929 cells
250 nM transferrin-TRITC (upper panel) or 0.5 mg/mL dextran-TexasRed (lower panel) for 60
colocalisation (yellow) between Sj.GST26 and both transferrin and neutral dextran.exogenous Sj.GST26. Through confocal microscopy we have observed
that Sj.GST26 is localised to endosomes within minutes of cellular
incubation (data not shown). Subsequent ﬁxation and nuclear staining
of cells loaded with Sj.GST26 (Fig. 8A) revealed that these vesicles
accumulate in a discrete perinuclear region after 1 h. The Golgi
apparatus, also located adjacent to the nucleus, is pivotal tomembrane
trafﬁc affecting transport within both endocytic and secretory path-
ways [23].We examinedwhether Sj.GST26-containingvesiclesmigrate
to a region of cells stained with BODIPY TR C5-ceramide, a structural
marker for the Golgi complex [24]. Fig. 8B shows that vesicular Sj.
GST26 ﬂuorescence, whilst predominantly situated in regions stained
with C5-ceramide, is not sufﬁciently colocalised to indicate that these
vesicles are docking with the Golgi apparatus. For comparison, an
endoplasmic reticulum labellingdrug, ER-Tracker™Red,was employed
and also found distributed within a perinuclear region similar to both
the Golgi marker and Sj.GST26 localised areas of L-929 cells (Fig. 8C).
Given these results, it is difﬁcult to conclude whether Sj.GST26-
containing vesicles are migrating to the Golgi complex. However
confocal microscopy of cells treated with brefeldin A, which disrupts
trafﬁc within the trans-Golgi network [25,26], did not change the
perinuclear localisation of Sj.GST26 vesicles (data not shown) inferring
that vesicles are not interacting with the Golgi complex.
Clathrin-coated pits containing transferrin are sorted for recycling
in a perinuclear region of the cell termed the perinuclear recycling
compartment (PNRC) [22,27], which has a pH ∼5.6 and is physically
distinct from the Golgi apparatus [28]. Dextran-ﬁlled late endosomes
and lysosomes also accumulate in a perinuclear region separate to the
Golgi which is proposed to be the PNRC [28]. Given the potential
involvement of CME and macropinocytosis in Sj.GST26 transduction,
and the absence of colocalisation with the Golgi apparatus, it seems
likely that ﬂuorescent Sj.GST26 accumulates in the PNRC for further
processing. Whether Sj.GST26 is subsequently degraded, recycled towere serum-starved for 30min then co-incubated with 100 nM Sj.GST26-OG plus either
min. Cells were washed and observed live by confocal microscopy. Note the signiﬁcant
Fig. 8. Perinuclear Sj.GST26 ﬂuorescence is not localised to the Golgi or ER. (A) L-929 cells treated for 1 h with Sj.GST26-OG were ﬁxed and nuclei stained with 7-AAD. Note the
perinuclear punctate ﬂuorescence of Sj.GST26. To investigate this region of Sj.GST26 ﬂuorescence, L-929 cells were stained with BODIPY TR C5-ceramide for 30 min at 4 °C for Golgi
visualisation, washed, then incubated with Sj.GST26-OG for 1 h (B), or incubated with Sj.GST26-OG for 2 h then ER-Tracker™ Red added for a further 15 min to visualise the
endoplasmic reticulum (C). Whilst Sj.GST26 ﬂuorescence is within the region of both the Golgi and ER, pixels in merged images do not overlap thereby ruling out colocalisation.
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quantities (as suggested in [2]), is yet to be clariﬁed, but preliminary
results demonstrate that intracellular Oregon Green ﬂuorescence is
stable for several hours.
3.5. The GST-fold motif determines cell transduction
The cytosolic GST gene family can be subdivided into a number of
different classes which, despite having relatively low sequence
homology, share a similar structure known as the ‘GST-fold’ (Fig. 1)
[11]. In addition to these classical GSTs, four proteins that contain the
GST-fold but possess no signiﬁcant glutathione-conjugating enzyme
activity have been identiﬁed — human CLIC2 (Chloride Intracellular
Channel 2) and GDAP1 (Ganglioside-induced differentiation-asso-
ciated protein 1), S. cerevisiae Ure2 and E. coli Glutaredoxin-2 (Grx2).
The functions of these ‘GST-fold’ proteins vary widely; CLIC2 acts toregulate the cardiac ryanodine receptor 2 channels [12,29,30], GDAP1
is highly expressed in the whole brain and spinal cord with mutations
causing damage to the peripheral nervous system (Charcot-Marie-
Tooth disease) [14], Ure2 acts to negatively regulate GATA factor-
mediated transcription in yeast [31], and Grx2 catalyses GSH-disulﬁde
oxidoreductions [32].
To determine if the GST-fold structure is important for membrane
transduction, we examined the ability of several mammalian cytosolic
GST isoforms and the four non-GST proteins possessing a GST-fold, to
penetrate L-929 cells along with Sj.GST26. The cellular uptake of all
proteins was quantitatively evaluated over time by ﬂow cytometry
analysis (see Methods), and the standardised intracellular ﬂuores-
cence after 3 h incubation is displayed in Fig. 9. The most efﬁcient
transductionwas produced by the protein CLIC2, and all other GST and
GST-fold proteins fall in a tight range above the two negative control
proteins, BSA and GSH-S. In light of these results, key amino acids that
Fig. 9. Proteins containing a GST-fold structure are efﬁciently internalised by L-929 cells.
Cells were incubated with 200 nM Oregon Green-labelled proteins for 3 h and
intracellular ﬂuorescence measured by ﬂow cytometry. The mean cell ﬂuorescence of
each sample was normalised for the degree of ﬂuorescent labelling of that protein. Error
bars represent the SEM of three independent experiments.
Fig. 10. Active-site mutants of GSTs show increased cellular uptake in L-929 cells
compared with wild-type GSTs. The effect of mutating catalytically important residues
on GST transductionwas examined for GSTA1 (Y9F), GSTM2-2 (Y7F) and GSTO1 (C32A).
L-929 cells were incubated with 200 nM Oregon Green-labelled proteins for 3 h and
intracellular ﬂuorescence measured by ﬂow cytometry. The mean cell ﬂuorescence of
each sample was normalised for the degree of ﬂuorescent labelling of that protein. Error
bars represent the S.D. of three independent experiments.
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their role in transduction. Intriguingly, the cellular uptake of the
GSTA1, GSTM2 and GSTO1 mutants (Y9F, Y7F and C32A respectively),
exceeded that of the wild-type proteins by 1.4 to 5-fold (Fig. 10). The
fact that wild-type GST enzymes, their active-site mutants, and the
GST-fold proteins are all capable of efﬁcient internalisation into L-929
cells, suggests that it is the structural fold of these proteins that
enables membrane transduction. The route of uptake of GSTs from the
Zeta and Mu classes was further characterised in the presence of
several metabolic inhibitors and endocytosis markers, and found to
share the same trends of inhibition and colocalisation proﬁles as Sj.
GST26 (data not shown), indicating that the same endocytosis
pathways are utilised in the uptake of these GST-fold proteins.
4. Discussion
In this study we examined the internalisation kinetics, cellular
speciﬁcity and mechanism of cellular entry of a GST from S. japonicum
using quantitative ﬂow cytometry and confocal microscopy. In
addition, a quantitative comparison of the transduction efﬁciency of
a range of mammalian GSTs from different evolutionary classes, as
well as proteins with a GST-fold structure but lacking GST enzyme
activity, was undertaken.
Comparative analysis of the cellular uptake of ﬂuorescently-
labelled Sj.GST26, transferrin, BSA and GSH-S demonstrated that the
rate of cellular Sj.GST26 uptake is more rapid than transferrin, whilst
the internalisation of control proteins BSA and GSH-S is minimal. This
suggests that the mechanism underlying Sj.GST26 transduction is a
rapid and efﬁcient process and not simply a background event
resulting from constitutive sampling of the culture medium. Visuali-
sation of Sj.GST26 in cells revealed punctate cytoplasmic ﬂuorescence,
and the pH sensitive fusion protein Sj.GST26-mOrange further
demonstrated that these punctate vesicles are acidic in nature,
implicating endocytosis as the process responsible for internalisation.
These microscopy studies were performed on live cells to avoid any
possibility of artiﬁcial distribution from ﬁxation, however the
morphology of punctate vesicles did not alter when cells were ﬁxed
to allow nuclei labelling. In addition, the intracellular ﬂuorescence of
Sj.GST26-GFP eliminated any involvement of the Oregon Green
ﬂuorophore in Sj.GST26 transduction for this and previous studies [2].
A role for endocytosis in Sj.GST26 uptake was further supported by
the prevention of intracellular Sj.GST26 ﬂuorescence after cellularenergy depletion, and colocalisation of internalised protein with
transferrin and dextranmarker molecules. These results are in keeping
with recent data providing evidence for endocytic mechanisms in the
cell entry ofmany protein transduction domains [33–37]. Endocytosis is
responsible for the internalisation of hormones, growth factors, plasma
proteins and recyclingofmembrane components and receptors and can
occur through several distinct pathways within cells, including
macropinocytosis, CME, caveolin-mediated, and clathrin- and caveo-
lin-independent lipid raft pathways (reviewed in [38]).
The mechanism of uptake of an endocytosed molecule is known to
inﬂuence its subsequent intracellular trafﬁcking and fate, which is of
major signiﬁcance to the delivery of therapeutics into cells. The
migration of Sj.GST26-containing vesicles to a region consistent with
the perinuclear recycling compartment of cells is in agreement with
the employment of either CME or macropinocytosis pathways in Sj.
GST26 transduction, as late endosomes, lysosomes and recycling
endosomes are all known to accumulate in this subcellular compart-
ment [22,27,28]. It must be noted however, that the interconnecting
networks of endocytosis are poorly delineated, and macropinocytosis
markers (as well as lipid raft markers) have been demonstrated to
penetrate cells through multiple routes and also merge at the stage of
early endosomes [28,39,40]. It is therefore not possible to specify the
intracellular fate of this class of proteins after internalisation.
The cytosolic GST gene family can be subdivided into a number of
different classes that may be represented in a related group of species
or be found over awide phylogenetic range [11]. Usually, the sequence
identity between classes is less than 30% and is around 60% or higher
within classes [41]. In mammals, seven classes of cytosolic GST have
been described (Alpha, Mu, Omega, Pi, Sigma, Theta and Zeta) and
there may be multiple genes within each class [42]. Given that Sj.
GST26 has proven to be an efﬁcient cell transduction protein, we
wished to assess the ability of proteins from the mammalian cytosolic
GST classes to penetrate cells alongside Sj.GST26. Despite sharing little
primary sequence identity and utilising different active-site residues,
all cytosolic GST classes have the same basic structural fold. This GST-
fold consists of an N-terminal thioredoxin fold followed by a strongly
helical C-terminal domain [11], and is also possessed by a range of
‘GST-fold’ proteins which have no glutathione-dependent enzyme
activity. We therefore quantitatively compared the transduction
efﬁciency of GST proteins in parallel with several GST-fold proteins.
GSH-S was also included in this comparative study as a structural
684 M.J. Morris et al. / Biochimica et Biophysica Acta 1788 (2009) 676–685negative control since it has the ability to bind glutathione, but does
not share the GST-fold conformation.
All classes of GST tested so far have proven capable of rapid cell
transduction. In addition the four GST-fold proteins were also
internalised, in fact one of these proteins, CLIC2, was the most
efﬁciently transported. This indicates that the GST-fold structure is a
common feature present in cellular transduction and the enzymic
property of GST is not related to its ability to enter cells. Further
evidence for this hypothesis lies with the mutation of catalytically
important GST residues which, rather than impeding cell transduction
capacity, show a propensity to elevate the efﬁciency of cell entry.
Curiously, it has previously been shown that CLIC proteins, as well as
being members of the cytosolic GST structural family, can modulate
ryanodine receptor Ca2+ channels [43] and under certain conditions
even undergo a conformational change to enter membranes and form
ion channels directly [44]. It is possible that other GSTs may also enter
cell membranes to a limited extent, and this may facilitate or even
stimulate endocytosis. This concept is supported by the observation
that endogenous alpha class GSTs are capable of being reversibly
incorporated into, or in close proximity with, the plasma and nuclear
membranes of cells [4,5].
It has long been known that upon liver damage or disease there is a
large release of GSTs into the blood circulation. However, the half-life
of this circulating GST population is surprisingly short which
previously has been assumed to be due to degradation [45]. It is an
enticing notion to consider that rather than degradation, the loss of
circulating GST may be due to an inherent transduction mechanism
that allows external GST to be transported back into neighbouring
cells, with the potential to enhance self-defense in these cells to toxins
or free radicals that caused their initial release.
The mechanistic proﬁle of Sj.GST26 transduction outlined in this
study provides quantitative information on the efﬁciency and manner
in which GST-fold proteins may enter cells. We have shown that this
transport occurs through an energy-dependent process involving
endocytosis that also demonstrates cell speciﬁcity. Moreover, we
establish that proteins adopting a GST-fold are capable of traversing
into cells, and may represent a new class of transduction molecule.
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